Open AccessOutcomes of Ceftolozane/Tazobactam (C/T) in Patients With Moderate Renal Impairment in Two Phase 3 Trials for the Treatment of Complicated Intra-abdominal Infection (cIAI) and Complicated Urinary Tract Infection (cUTI)
Author(s) -
Melissa Palchak,
Myra W Popejoy,
Benjamin Miller
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.617
Subject(s) - medicine , ceftazidime/avibactam , urinary system , imipenem/cilastatin , gastroenterology , intensive care medicine , antibiotics , microbiology and biotechnology , imipenem , pseudomonas aeruginosa , bacteria , genetics , antibiotic resistance , biology , ceftazidime